Dusseldorf - Delayed Quote EUR

Oxford BioMedica PLC (OXOA.DU)

Compare
4.8400 -0.1200 (-2.42%)
As of 8:12:51 AM GMT+1. Market Open.
Currency in GBP All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
89,539.0000
89,539.0000
139,989.0000
142,797.0000
87,728.0000
Cost of Revenue
49,812.0000
49,812.0000
70,808.0000
60,157.0000
41,655.0000
Gross Profit
39,727.0000
39,727.0000
69,181.0000
82,640.0000
46,073.0000
Operating Expense
124,691.0000
124,691.0000
99,350.0000
61,707.0000
50,936.0000
Operating Income
-84,964.0000
-84,964.0000
-30,169.0000
20,933.0000
-4,863.0000
Net Non Operating Interest Income Expense
-6,289.0000
-6,289.0000
-7,781.0000
-888.0000
-878.0000
Pretax Income
-188,527.0000
-188,527.0000
-45,976.0000
19,880.0000
-6,572.0000
Tax Provision
-4,365.0000
-4,365.0000
-817.0000
869.0000
-327.0000
Net Income Common Stockholders
-157,490.0000
-157,490.0000
-39,157.0000
19,011.0000
-6,245.0000
Diluted NI Available to Com Stockholders
-157,490.0000
-157,490.0000
-39,157.0000
19,011.0000
-6,245.0000
Basic EPS
-1.63
-1.63
-0.41
0.23
-0.08
Diluted EPS
-1.63
-1.63
-0.41
0.22
-0.08
Basic Average Shares
96,555.3470
96,555.3470
94,829.8920
83,484.1730
79,944.9110
Diluted Average Shares
96,555.3470
96,555.3470
94,829.8920
85,618.6670
79,944.9110
Total Operating Income as Reported
-184,174.0000
-184,174.0000
-30,220.0000
20,768.0000
-5,694.0000
Rent Expense Supplemental
249.0000
249.0000
231.0000
236.0000
173.0000
Total Expenses
174,503.0000
174,503.0000
170,158.0000
121,864.0000
92,591.0000
Net Income from Continuing & Discontinued Operation
-157,490.0000
-157,490.0000
-39,157.0000
19,011.0000
-6,245.0000
Normalized Income
-60,577.0272
-60,577.0272
-39,106.9063
19,168.7875
-5,455.3477
Interest Income
4,910.0000
4,910.0000
973.0000
--
34.0000
Interest Expense
11,199.0000
11,199.0000
8,754.0000
888.0000
912.0000
Net Interest Income
-6,289.0000
-6,289.0000
-7,781.0000
-888.0000
-878.0000
EBIT
-177,328.0000
-177,328.0000
-37,222.0000
20,768.0000
-5,660.0000
EBITDA
-148,618.0000
-148,618.0000
-10,863.0000
33,224.0000
4,179.0000
Reconciled Cost of Revenue
49,812.0000
49,812.0000
70,808.0000
60,157.0000
41,655.0000
Reconciled Depreciation
28,710.0000
28,710.0000
26,359.0000
12,456.0000
9,839.0000
Net Income from Continuing Operation Net Minority Interest
-157,490.0000
-157,490.0000
-39,157.0000
19,011.0000
-6,245.0000
Total Unusual Items Excluding Goodwill
-99,210.0000
-99,210.0000
-51.0000
-165.0000
-831.0000
Total Unusual Items
-99,210.0000
-99,210.0000
-51.0000
-165.0000
-831.0000
Normalized EBITDA
-49,408.0000
-49,408.0000
-10,812.0000
33,389.0000
5,010.0000
Tax Rate for Calcs
0.0000
0.0000
0.0000
0.0000
0.0000
Tax Effect of Unusual Items
-2,297.0272
-2,297.0272
-0.9063
-7.2125
-41.3477
12/31/2020 - 3/22/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade